EUROAPI

Equities

EAPI

FR0014008VX5

Pharmaceuticals

Real-time Euronext Paris 10:00:30 2024-06-05 am EDT 5-day change 1st Jan Change
3.816 EUR +4.15% Intraday chart for EUROAPI +10.46% -33.26%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
EU okays $1.5 bln state funded joint hydrogen project, $1.1 bln joint healthcare project RE
Euroapi Secures Deal for Veterinary Chemical Molecule MT
Euroapi: major CMO agreement in animal health CF
EUROAPI Enters into Contract Manufacturing Organization Agreement with Global Animal Health Company CI
Euroapi appoints new CFO CF
EUROAPI Appoints Evelyne Nguyen as Chief Financial Officer CI
EUROAPIAppoints Evelyne Nguyen as Member of the Executive Committee CI
Euroapi Names New Chief Commercial Officer MT
Euroapi: tightening of executive committee CF
Euroapi S.A. Announces Executive and Executive Committee Changes CI
CAC40: ends in green, approaches 8200 points CF
CAC40: +0.3%, tops out at 8,180, same gap for US indices CF
CAC40: records in sight 48 hours before end of 1st quarter CF
Euroapi: Kopernik Global Investors crosses the 5% threshold CF
CAC40: falls back to equilibrium at the end of the session, +1.7% over the week CF
EUROAPI : Oddo lowers its target price CF
Euroapi: share price falls 16% after Brindisi shutdown CF
CAC40: 4 witches outperform, W-Street struggles CF
CAC40: clings to 8,200 for the '4 Witches' despite rates CF
CAC40: cautious trend before a salvo of statistics CF
CAC40: Slightly negative bias ahead of the 4 witches' day CF
Euroapi: production suspended in Brindisi CF
Euroapi Halts Pharmaceutical Ingredient Production at Italian Site Amid Quality Control Issues MT
Deutsche Bank Downgrades Euroapi to Sell from Hold, Cuts PT MT
EUROAPI : Deutsche Bank downgrades to 'sell CF
Chart EUROAPI
More charts
EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 6 production sites located in France (2), the United Kingdom, Germany, Italy and Hungary.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
3.664 EUR
Average target price
3.52 EUR
Spread / Average Target
-3.93%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. EAPI Stock
  4. News EUROAPI
  5. Euroapi, SpiroChem Team Up to Launch CRO-CDMO Offering